The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis
Simple Summary Colorectal cancer (CRC) is the third most common cancer worldwide.
Metastasis to secondary organs, such as the liver and lungs, is a key driver of CRC-related …
Metastasis to secondary organs, such as the liver and lungs, is a key driver of CRC-related …
[HTML][HTML] Management of single pulmonary metastases from colorectal cancer: State of the art
Colorectal cancer (CRC) is one of the most common causes of death from cancer. Lung
seeding occurs in approximately 10% of patients surgically treated for primary CRC with …
seeding occurs in approximately 10% of patients surgically treated for primary CRC with …
Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical …
MA Khattak, HL Martin, C Beeke, T Price… - Clinical colorectal …, 2012 - Elsevier
Background Colorectal cancer is the third most common cancer in Australia. The median
overall survival for metastatic colorectal cancer is nearly 2 years. However, there may be …
overall survival for metastatic colorectal cancer is nearly 2 years. However, there may be …
The characteristics of bone metastasis in patients with colorectal cancer: a long-term report from a single institution
Background Bone metastasis in patients with colorectal cancer (CRC) is very rare, and data
are extremely lacking. We aimed to evaluate the characteristics of bone metastasis in …
are extremely lacking. We aimed to evaluate the characteristics of bone metastasis in …
Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor
BR Lin, TC Chang, YC Lee, PH Lee, KJ Chang… - Annals of surgical …, 2009 - Springer
Background Pulmonary resection is the most effective treatment available for colorectal lung
metastases. However, the characteristics of those patients most likely to benefit from surgical …
metastases. However, the characteristics of those patients most likely to benefit from surgical …
Altered expression profiles of circular RNA in colorectal cancer tissues from patients with lung metastasis
Y Zeng, Y Xu, R Shu, L Sun, Y Tian… - International …, 2017 - spandidos-publications.com
The lung is the most common extra-abdominal site of metastasis in colorectal cancer (CRC),
in which circular RNA (circRNA) may have a crucial role. Therefore, the present study …
in which circular RNA (circRNA) may have a crucial role. Therefore, the present study …
Surgical management of pulmonary metastases
L Erhunmwunsee, TA D'Amico - The Annals of thoracic surgery, 2009 - Elsevier
Metastasectomy is the only curative option for some patients with secondary pulmonary
malignancy. Many studies suggest a survival benefit in selected patients if complete …
malignancy. Many studies suggest a survival benefit in selected patients if complete …
[HTML][HTML] Phase II multicenter clinical trial of pulmonary metastasectomy and isolated lung perfusion with melphalan in patients with resectable lung metastases
WA Den Hengst, JMH Hendriks, B Balduyck… - Journal of thoracic …, 2014 - Elsevier
Introduction The 5-year overall survival rate of patients undergoing complete surgical
resection of pulmonary metastases (PM) from colorectal cancer (CRC) and sarcoma remains …
resection of pulmonary metastases (PM) from colorectal cancer (CRC) and sarcoma remains …
Surgery for colorectal liver metastases
SJ McNally, RW Parks - Digestive surgery, 2014 - karger.com
Half of all patients with colorectal cancer develop metastatic disease. The liver is the
principal site for metastases, and surgical resection is the only modality that offers the …
principal site for metastases, and surgical resection is the only modality that offers the …
Aggressive treatment of primary tumor in patients with non–small-cell lung cancer and exclusively brain metastases
C Villarreal-Garza, D De La Mata, DG Zavala… - Clinical lung cancer, 2013 - Elsevier
Abstract Between 30% and 50% of patients with non–small-cell lung cancer (NSCLC) will
develop cerebral metastases in the course of their illness. As improvements are made in the …
develop cerebral metastases in the course of their illness. As improvements are made in the …